. Author manuscript; available in PMC: 2024 Nov 1.

Published in final edited form as: Eur J Radiol. 2023 Sep 13;168:111095. doi: 10.1016/j.ejrad.2023.111095

Table 2 –

Overall distribution of recurrent prostate cancer and standalone AI detection sensitivity

Treatment Technique	No. of Pts.	PCa Foci	AI: Lesion-level Sensitivity		PC a Pts.	AI: Patient-level Sensitivity		FPs per patient		FNs per patient
Treatment Technique	No. of Pts.	PCa Foci	Ratio	%	PC a Pts.	Ratio	%	Mean	Median [range]	Mean	Median [range]
EBRT	36	34	27/34	79.4	27	22/27	81.5	0.36	0 [0, 2]	0.19	0 [0, 1]
BT	26	22	13/22	59.1	19	13/19	68.4	0.34	0 [0, 2]	0.34	0 [0, 2]
Overall	62	56	40/56	71.4	46	35/46	76.1	0.35	0 [0, 2]	0.25	0 [0, 2]

AI: Artificial Intelligence model, BT: Brachytherapy, EBRT: External beam radiation therapy, PCa: Prostate cancer, FP: False positive, FN: False negative.